Supreme Court Denies Vanda Pharma’ Petition In HETLIOZ Litigation Against Teva, Apotex

(RTTNews) – The U.S. Supreme Court denied Vanda Pharmaceuticals Inc.’s (VNDA) petition for a writ of certiorari in its HETLIOZ Abbreviated New Drug Application litigation against Teva Pharmaceuticals USA Inc., Apotex Inc. and Apotex Corp.

“We are disappointed that the Supreme Court has decided not to hear our c